$162.55
-0.97 (-0.593%)
At Close: Jul 31, 2026
Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?
04:19pm, Tuesday, 19'th May 2026
The iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) is the rare fund that has spent the past year being publicly threatened by the President of the United States and quietly outperforming nearly every
How I Would Build A Near-Perfect 8%-Yielding Retirement Portfolio Right Now
07:30am, Monday, 18'th May 2026
There are several different paths to retiring on dividends. However, they all have major drawbacks. I share an approach that I have honed over time that seeks to bring out the best of each strategy an
Why the Healthcare Sector Warrants Concentrated Exposure
03:32pm, Wednesday, 13'th May 2026
Sure, portfolio diversification may be important, but some equity sectors currently look a bit more promising than others. Key Takeaways: Diversification may be a valuable portfolio approach, but indi
The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics
11:41am, Wednesday, 13'th May 2026
ETFs like XLV stand out as aging U.S. demographics fuel rising demand for healthcare, medical devices and senior-focused care.
April Jobs Data Put Focus on These Sector ETFs & Stocks
11:02am, Wednesday, 13'th May 2026
April jobs beat forecasts as healthcare, transportation and retail hiring stayed resilient. These sector ETFs and stocks may stay active.
Nasdaq Tops 29,000 Records, Micron Soars 13%: Stock Market Today
01:36pm, Friday, 08'th May 2026
Nasdaq jumps 1.6% to record highs Friday as semiconductor rally and stronger-than-expected April payrolls overshadow ongoing Strait of Hormuz tensions.
Healthcare's Defensive Promise Crumbles: XLV Down 7% While SPY Rises 5% in 2026
07:23am, Wednesday, 29'th Apr 2026
Healthcare is supposed to be the place you hide. It is the fourth-largest slice of U.S.
Healthcare is not always the most exciting sector to own, and the companies in it grind it out, quarter after quarter, raise dividends quietly, and generally do not produce the kind of explosive retur
Kopp Family Office Trims $3.5 Million Worth of Viridian Therapeutics Stake -- What Investors Should Know
03:26pm, Tuesday, 21'st Apr 2026
Viridian Therapeutics is a clinical-stage biotech awaiting an FDA decision on its lead thyroid eye disease therapy.
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
07:20am, Monday, 20'th Apr 2026
Launched on December 16, 1998, the State Street Health Care Select Sector SPDR ETF ETF (XLV) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad
What Johnson & Johnson Earnings Signal for Healthcare ETFs
04:51pm, Tuesday, 14'th Apr 2026
With Q1 earnings season well underway, it was Johnson & Johnson (JNJ) giving investors a peek at how the broader healthcare sector might perform. The healthcare giant beat expectations on Tuesday in r
Likely Sector ETF & Stock Winners From March Jobs Report
02:00pm, Monday, 06'th Apr 2026
March jobs data highlights sector winners -- Healthcare, Transport & Construction ETFs gain as hiring rebounds and steady demand supports growth.
Health Care Select Sector SPDR Fund (NYSEARCA:XLV) Share Price Crosses Below 200 Day Moving Average – Here’s Why
03:11am, Friday, 03'rd Apr 2026
Health Care Select Sector SPDR Fund (NYSEARCA:XLV - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $150.7
Consumer Sentiment Weakens: ETFs That Are Worth a Look
01:40pm, Wednesday, 01'st Apr 2026
Rising oil prices and Middle East tensions are squeezing household finances and weakening consumer sentiment, steering investors toward defensive ETFs.
The Big 3: XLV, BA, SAP
01:00pm, Wednesday, 25'th Mar 2026
Traders "live for days like these," says @Theotrade's Don Kaufman in referencing Wednesday's volatility. He offers a trio of example options trades he sees as opportunities in the price action.
Sign In
Buy XLV